Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide dosing for weight loss follows a gradual titration schedule, typically beginning at 0.25 mg weekly and increasing every four weeks until reaching a therapeutic dose of 1.7–2.4 mg per week. The optimal dose is not fixed; it depends on your individual metabolic response, gastrointestinal tolerance, and weight loss goals.

Many patients assume a higher dose equals better results, but clinical evidence and real-world outcomes suggest the most effective dose is the one you can tolerate consistently while achieving meaningful weight loss. PlexusDx supports precision wellness by helping you understand your individual response factors—including genetic predispositions—so conversations with your provider become more targeted and informed.

How Semaglutide Dosing Works: The Titration Timeline

Semaglutide's effect on appetite and weight loss emerges gradually as your body adapts. The standard protocol involves four weekly injections at each dose level before increasing. This slow ramp prevents nausea and other gastrointestinal side effects while allowing your system to acclimate.

Most patients reach maintenance doses between 1.7 and 2.4 mg weekly within 16–20 weeks. Some individuals achieve meaningful weight loss at lower doses, while others may benefit from the higher end of the range. Your provider monitors your response and adjusts timing based on tolerance and progress toward your weight loss goals.

Individual Response Factors: Beyond Dose Numbers

The 'best' semaglutide dose is not determined by a chart; it emerges through guided trial and adjustment. Individual factors—including insulin sensitivity, baseline metabolic rate, GLP-1 receptor sensitivity, and gastrointestinal tolerance—all influence which dose produces the most benefit with the fewest side effects.

Research shows that dose response is heterogeneous. Two patients on identical doses may experience different appetite suppression, weight loss rates, and side effect profiles. This variation is why working closely with your provider during titration matters more than rushing to a higher dose.

Factor Clinical Relevance to Dosing
GLP-1 Receptor Sensitivity Individuals with higher baseline GLP-1R activity may respond at lower doses; those with lower sensitivity may require higher therapeutic doses.
Insulin Resistance Status Patients with significant insulin resistance may show improved metabolic response at higher doses; lean individuals may achieve goals at lower doses.
Gastrointestinal Tolerance Nausea, vomiting, or constipation at a given dose may require slower titration or a slightly lower maintenance dose while still achieving weight loss.
Baseline Body Weight & Composition Heavier individuals and those with greater fat mass often require higher doses for clinically meaningful weight loss compared to lighter-weight users.

Clinical Evidence on Dose and Weight Loss Outcomes

Phase 3 trials (STEP 1–4) demonstrated dose-dependent weight loss: 0.25 mg showed minimal loss, 0.5 mg produced ~5% reduction, 1 mg ~10%, and 2.4 mg ~15% weight reduction. However, these are population averages; individual responses varied significantly around these means.

Real-world data suggests many patients plateau on weight loss before reaching the maximum labeled dose. Continuing to increase dose beyond the point of clinical benefit and tolerability does not reliably yield further weight loss and may increase side effect burden. Your provider's role is identifying your optimal dose, not the highest possible dose.

Safety, Tolerance, and When to Adjust Your Dose

Semaglutide is generally well-tolerated when dosed appropriately, but dose-related side effects—primarily nausea, vomiting, and constipation—occur in a subset of patients. If side effects become intolerable at a given dose level, staying at a lower maintenance dose is medically sound; weight loss efficacy at a tolerable dose outweighs the pursuit of a higher, poorly tolerated dose.

Dose adjustments should always be made under provider guidance. Do not skip doses or self-increase in hopes of faster results. Conversely, if your weight loss plateaus at your current dose for 6–8 weeks, your provider may recommend a slower or faster titration strategy based on your overall response pattern and medical history. This is personalized medicine in practice—not a standardized protocol.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test examines predispositions in GLP-1 receptor sensitivity (GLP1R rs6923761), GIPR signaling (GIPR rs1800437), and metabolic factors (FTO rs9939609, MC4R rs17782313). These variants may help provide context about your individual receptor function and metabolic baseline—potentially informing whether you might respond optimally at a lower maintenance dose or may benefit from exploring the full titration range.

The genetic test reveals predispositions in peptide receptor pathways, not a guarantee of how you will respond to semaglutide. Two patients with identical genetic profiles may still experience different dose responses based on other factors: age, medications, comorbidities, lifestyle, and stress. The test should be interpreted with a qualified healthcare provider as one data point among many.

Understanding your genetic predispositions can help you and your provider have a more informed conversation about realistic starting points, expected titration pace, and factors that might influence your individual response. This approach supports precision dosing rather than guesswork—ensuring your treatment plan aligns with your biology, not a statistical average.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves